Literature DB >> 21966234

During influenza season, which children need an antiviral and which one should I prescribe? Do I need to verify that they have influenza first?

M Bowman1, Se Forgie.   

Abstract

Entities:  

Year:  2010        PMID： 21966234      PMCID： PMC2952515          DOI： 10.1093/pch/15.8.499

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  22 in total

1.  Children hospitalized with influenza during the 2006-2007 season: a report from the Canadian Immunization Monitoring Program, Active (IMPACT).

Authors:  C Burton; W Vaudry; D Moore; D Scheifele; J Bettinger; S Halperin; T Tam; B Law
Journal:  Can Commun Dis Rep       Date:  2008-12

2.  Clinical characteristics of paediatric H1N1 admissions in Birmingham, UK.

Authors:  S Hackett; L Hill; J Patel; N Ratnaraja; A Ifeyinwa; M Farooqi; U Nusgen; P Debenham; D Gandhi; N Makwana; E Smit; S Welch
Journal:  Lancet       Date:  2009-08-22       Impact factor: 79.321

3.  Pandemic H1N1 influenza in the pediatric emergency department: a comparison with previous seasonal influenza outbreaks.

Authors:  Brian E Costello; Harold K Simon; Robert Massey; Daniel A Hirsh
Journal:  Ann Emerg Med       Date:  2010-04-03       Impact factor: 5.721

4.  Oral oseltamivir treatment of influenza in children.

Authors:  R J Whitley; F G Hayden; K S Reisinger; N Young; R Dutkowski; D Ipe; R G Mills; P Ward
Journal:  Pediatr Infect Dis J       Date:  2001-02       Impact factor: 2.129

5.  Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial.

Authors:  J A Hedrick; A Barzilai; U Behre; F W Henderson; J Hammond; L Reilly; O Keene
Journal:  Pediatr Infect Dis J       Date:  2000-05       Impact factor: 2.129

Review 6.  Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials.

Authors:  Matthew Shun-Shin; Matthew Thompson; Carl Heneghan; Rafael Perera; Anthony Harnden; David Mant
Journal:  BMJ       Date:  2009-08-10

7.  Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.

Authors:  Tiffany G Sheu; Varough M Deyde; Margaret Okomo-Adhiambo; Rebecca J Garten; Xiyan Xu; Rick A Bright; Eboneé N Butler; Teresa R Wallis; Alexander I Klimov; Larisa V Gubareva
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

8.  Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada.

Authors:  Allison McGeer; Karen A Green; Agron Plevneshi; Altynay Shigayeva; Nilofar Siddiqi; Janet Raboud; Donald E Low
Journal:  Clin Infect Dis       Date:  2007-12-15       Impact factor: 9.079

9.  Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States.

Authors:  Nila J Dharan; Larisa V Gubareva; John J Meyer; Margaret Okomo-Adhiambo; Reginald C McClinton; Steven A Marshall; Kirsten St George; Scott Epperson; Lynnette Brammer; Alexander I Klimov; Joseph S Bresee; Alicia M Fry
Journal:  JAMA       Date:  2009-03-02       Impact factor: 56.272

10.  Viral loads and duration of viral shedding in adult patients hospitalized with influenza.

Authors:  Nelson Lee; Paul K S Chan; David S C Hui; Timothy H Rainer; Eric Wong; Kin-Wing Choi; Grace C Y Lui; Bonnie C K Wong; Rita Y K Wong; Wai-Yip Lam; Ida M T Chu; Raymond W M Lai; Clive S Cockram; Joseph J Y Sung
Journal:  J Infect Dis       Date:  2009-08-15       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.